Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma
We investigated antimicrobial drug resistance in ocular Chlamydia trachomatis 18 months after 4 biannual communitywide distributions of antimicrobial drugs in a region of Ethiopia where ocular strains of C. trachomatis are highly endemic. We found no significant differences in susceptibilities to az...
Main Authors: | Kevin Cyrus Hong, Julius Schachter, Jeanne Moncada, Zhaoxia Zhou, Jenafir House, Thomas M. Lietman |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2009-07-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/15/7/08-1563_article |
Similar Items
-
Eliminating Trachoma in Areas with Limited Disease
by: Bruce D. Gaynor, et al.
Published: (2003-05-01) -
Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal
by: Emma M. Harding-Esch, et al.
Published: (2019-10-01) -
Trachoma Decline and Widespread Use of Antimicrobial Drugs
by: Jaya D. Chidambaram, et al.
Published: (2004-11-01) -
Chlamydia trachomatis as a cause of trachoma
by: Marić V., et al.
Published: (2015-01-01) -
Short-term increase in prevalence of nasopharyngeal carriage of macrolide-resistant Staphylococcus aureus following mass drug administration with azithromycin for trachoma control
by: Ebrima Bojang, et al.
Published: (2017-03-01)